Laura C. Michaelis (@lauracmichaelis) 's Twitter Profile
Laura C. Michaelis

@lauracmichaelis

Hematologist and clinical researcher at Medical College of Wisconsin in Milwaukee. Views are my own.

ID: 2798834044

calendar_today01-10-2014 19:51:14

848 Tweet

1,1K Followers

1,1K Following

Laura C. Michaelis (@lauracmichaelis) 's Twitter Profile Photo

Heads Up! Medical College of Wisconsin is looking for interested folks to join our rapidly growing heme/onc division as oncologic hospitalists. Great colleagues, diverse research opportunities. Interested? DM me or reach out to Kim at 414-805-4600.

Akriti Jain (@akritigjain) 's Twitter Profile Photo

Learning a lot about clinical trial design with a great group of leukemia enthusiasts/physicians! PDG 08 AACR ASCO Methods in Clinical Cancer Research Workshop 2022

Learning a lot about clinical trial design with a great group of leukemia enthusiasts/physicians! PDG 08 <a href="/AACR/">AACR</a> <a href="/ASCO/">ASCO</a> Methods in Clinical Cancer Research Workshop 2022
Laura C. Michaelis (@lauracmichaelis) 's Twitter Profile Photo

Shaji Kumar Named Editor-in-Chief of The Hematologist - Hematology.org - So excited for the next chapter of this great publication. Thanks ⁦Shaji Kumar⁩ for taking the reins. hematology.org/newsroom/press…

ASH (@ash_hematology) 's Twitter Profile Photo

ASH wants to ensure the health & safety of all #ASH22 attendees in New Orleans ⚜️ Do your part by reviewing this year's protocols on vaccinations, masking requirements, COVID-19 testing, & more: loom.ly/_mT5VbQ Check out the 🧵⬇️ for a protocol prep tweetorial!

ASH wants to ensure the health &amp; safety of all #ASH22 attendees in New Orleans ⚜️ Do your part by reviewing this year's protocols on vaccinations, masking requirements, COVID-19 testing, &amp; more: loom.ly/_mT5VbQ 

Check out the 🧵⬇️ for a protocol prep tweetorial!
Jessica Altman, MD (@jaltmanmd) 's Twitter Profile Photo

#ASH22 night 1. So lucky to call these #WomenInLeukemia friends and colleagues. ⁦Eunice Wang MD⁩ ⁦Laura C. Michaelis⁩ Dr. Courtney DiNardo of ⁦MD Anderson Cancer Center⁩, and Dr. Kristen O’Dwyer of ⁦University of Rochester⁩. #AMLsm #ALLsm ⁦ASH⁩ 🧡

#ASH22 night 1. So lucky to call these #WomenInLeukemia friends and colleagues. ⁦<a href="/EuniceWangMD/">Eunice Wang MD</a>⁩ ⁦<a href="/lauracmichaelis/">Laura C. Michaelis</a>⁩ Dr. Courtney DiNardo of ⁦<a href="/MDAndersonNews/">MD Anderson Cancer Center</a>⁩, and Dr. Kristen O’Dwyer of ⁦<a href="/UofR/">University of Rochester</a>⁩. #AMLsm #ALLsm ⁦<a href="/ASH_hematology/">ASH</a>⁩ 🧡
Beth Psaila (@beth_psaila) 's Twitter Profile Photo

Such exciting data for patients with CALRmut MPNs. A great example of how industry-academia collaborations can accelerate development of novel therapies. Lovely work from Edimara Reis and colleagues Incyte Hitchcock Lab Plo isabelle and others

Such exciting data for patients with CALRmut MPNs. A great example of how industry-academia collaborations can accelerate development of novel therapies. Lovely work from Edimara Reis and colleagues <a href="/Incyte/">Incyte</a> <a href="/hitchcock_lab/">Hitchcock Lab</a> <a href="/isabelle_plo/">Plo isabelle</a> and others
Sameem Abedin (@sameem_abedin) 's Twitter Profile Photo

#ASH22. After single induction (7+3), for residual disease, lower intensity re-induction (Ven/HMA) was feasible and comparable to another cycle of 7+3, leading to less time in the hospital, NF and transfusions. MCW experience, but now a widespread practice.

#ASH22. After single induction (7+3), for residual disease, lower intensity re-induction (Ven/HMA) was feasible and comparable to another cycle of 7+3, leading to less time in the hospital, NF and transfusions. MCW experience, but now a widespread practice.
Jessica Altman, MD (@jaltmanmd) 's Twitter Profile Photo

Fabulous #mentorship on display during the #AMLsm oral session 616 today #ASH22. I want to call out Tapan Kadia mentoring Patrick Reville, MD, MPH, Dr. Martinelli mentoring Dr. Marconi, Dr. Wei mentoring Dr. Chong Chyn Chua just from this session. This is what ASH is about.

Nirav Shah (@niravshahmd) 's Twitter Profile Photo

Stop by our MCL poster Tim Fenske will be presenting tonight! 10 patients with R/R MCL s/p bispecific CAR20.19 T cells. ORR 100%, no relapses to date, median follow up 20 months! Mehdi Hamadani, MD #ASH22

Stop by our MCL poster <a href="/timfenske/">Tim Fenske</a> will be presenting tonight! 10 patients with R/R MCL s/p bispecific CAR20.19 T cells. ORR 100%, no relapses to date, median follow up 20 months! <a href="/MediHumdani/">Mehdi Hamadani, MD</a> #ASH22
Laura C. Michaelis (@lauracmichaelis) 's Twitter Profile Photo

Long line at #ASH22 Power Nap kiosk — maybe important endpoint when measuring efficacy of Sunday night parties? #docswhonap #dontshamesleep

Long line at #ASH22 Power Nap kiosk — maybe important endpoint when measuring efficacy of Sunday night parties? #docswhonap #dontshamesleep
Naveen Pemmaraju, MD (@doctorpemm) 's Twitter Profile Photo

Big shout out 🙏🏾 to Ruben Mesa Ruben A. Mesa, MD for the kind invitation & graciously hosting & bringing us together at 13th Biennial Joyce Niblak MPN Meeting Phoenix AZ 👏🏽 allowing us to raise awareness about MPNs L➡️R Ruben A. Mesa, MD Dr Laura C. Michaelis Naveen Pemmaraju, MD & Dr John Mascarenhas | #MPNSM

Big shout out 🙏🏾 to Ruben Mesa <a href="/mpdrc/">Ruben A. Mesa, MD</a> for the kind invitation &amp; graciously hosting &amp; bringing us together at 13th Biennial Joyce Niblak MPN Meeting Phoenix AZ 👏🏽 allowing us to raise awareness about MPNs L➡️R <a href="/mpdrc/">Ruben A. Mesa, MD</a> Dr <a href="/lauracmichaelis/">Laura C. Michaelis</a> <a href="/doctorpemm/">Naveen Pemmaraju, MD</a> &amp; Dr John Mascarenhas | #MPNSM
Nirav Shah (@niravshahmd) 's Twitter Profile Photo

In October 2017, we treated our first patient on a dose-escalation Phase 1 trial with bispecific anti-CD20/anti-CD19 CAR-T cell product utilizing a point-of-care manufacturing system. Many early skeptics, multiple grant rejections. Our team persevered!

Laura C. Michaelis (@lauracmichaelis) 's Twitter Profile Photo

MCW Cancer Center is hiring cancer docs! Interested in joining a rapidly growing, mission driven and research oriented cancer team? We have new positions open for thoracic, gastrointestinal and hematologic/heme malignancy specialists. DM me or email [email protected]